128 related articles for article (PubMed ID: 8918508)
1. Impaired haemostatic kinetics and endothelial function in Behçet's disease.
Haznedaroglu IC; Ozcebe OI; Ozdemir O; Celik I; Dündar SV; Kirazli S
J Intern Med; 1996 Oct; 240(4):181-7. PubMed ID: 8918508
[TBL] [Abstract][Full Text] [Related]
2. Pathological haemostasis and "prothrombotic state" in Behçet's disease.
Kiraz S; Ertenli I; Oztürk MA; Haznedaroğlu IC; Celik I; Calgüneri M
Thromb Res; 2002 Jan; 105(2):125-33. PubMed ID: 11958802
[TBL] [Abstract][Full Text] [Related]
3. [Subclinical pro-thrombotic state in a relapse of Behcet's disease--case report].
Undas A; Pinis G
Pol Arch Med Wewn; 1996 Sep; 96(3):258-62. PubMed ID: 9122017
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome.
Cekmen M; Evereklioglu C; Er H; Inalöz HS; Doganay S; Türköz Y; Ozerol IH
Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202
[TBL] [Abstract][Full Text] [Related]
5. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC
Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405
[TBL] [Abstract][Full Text] [Related]
6. Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity.
Fernández-Bello I; López-Longo FJ; Arias-Salgado EG; Jiménez-Yuste V; Butta NV
Orphanet J Rare Dis; 2013 May; 8():81. PubMed ID: 23711081
[TBL] [Abstract][Full Text] [Related]
7. Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.
Yuksel M; Yildiz A; Oylumlu M; Turkcu FM; Bilik MZ; Ekinci A; Elbey B; Tekbas E; Alan S
Clin Rheumatol; 2016 Mar; 35(3):701-8. PubMed ID: 25744156
[TBL] [Abstract][Full Text] [Related]
8. [Parameters of hemostasis in Behçet's disease].
Dupuy E; Tobelem G; Bourgeois P; Soria C; Pellerin A; Bellucci S; Caen JP
Rev Med Interne; 1983 Dec; 4(4):317-21. PubMed ID: 6665348
[TBL] [Abstract][Full Text] [Related]
9. Evidence for an endothelial cell dysfunction in association with Behçet's disease.
Schmitz-Huebner U; Knop J
Thromb Res; 1984 May; 34(4):277-85. PubMed ID: 6429888
[TBL] [Abstract][Full Text] [Related]
10. Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behçet's disease: evidence of a prethrombotic state.
Ozatli D; Sayinalp N; Büyükaşik Y; Karakuş S; Haznedaroglu IC; Kirazli S; Ozcebe O; Dündar SV
Rheumatol Int; 2002 Jan; 21(4):137-40. PubMed ID: 11843168
[TBL] [Abstract][Full Text] [Related]
11. Endothelial functions in Behçet's disease.
Kayikçioğlu M; Aksu K; Hasdemir C; Keser G; Turgan N; Kültürsay H; Doganavsargil E
Rheumatol Int; 2006 Feb; 26(4):304-8. PubMed ID: 15739096
[TBL] [Abstract][Full Text] [Related]
12. Coagulation and fibrinolytic activity in Behçet's disease.
Hampton KK; Chamberlain MA; Menon DK; Davies JA
Thromb Haemost; 1991 Sep; 66(3):292-4. PubMed ID: 1745999
[TBL] [Abstract][Full Text] [Related]
13. Coagulation parameters and plasma total homocysteine levels in Behcet's disease.
Lee YJ; Kang SW; Yang JI; Choi YM; Sheen D; Lee EB; Choi SW; Song YW
Thromb Res; 2002 Apr; 106(1):19-24. PubMed ID: 12165284
[TBL] [Abstract][Full Text] [Related]
14. Elevated oxidative stress markers and its relationship with endothelial dysfunction in Behçet disease.
Acikgoz N; Ermiş N; Yağmur J; Cansel M; Karincaoğlu Y; Ataş H; Cuglan B; Barutcu I; Pekdemir H; Özdemir R
Angiology; 2011 May; 62(4):296-300. PubMed ID: 20947865
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome.
Chambers JC; Haskard DO; Kooner JS
J Am Coll Cardiol; 2001 Feb; 37(2):517-20. PubMed ID: 11216972
[TBL] [Abstract][Full Text] [Related]
16. Lectin-like oxidised LDL receptor-1 as a marker of endothelial dysfunction in Behçet's disease.
Ozyazgan S; Uzun H; Onal B; Tuzcu A; Ugurlu S; Andican G
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):71-6. PubMed ID: 24064019
[TBL] [Abstract][Full Text] [Related]
17. [Is Behçet's disease associated with characteristic abnormalities of coagulation and fibrinolysis? Apropos of 70 case reports].
Conard J; Horellou MH; Wechsler B; Fassin D; Bletry O; Godeau P; Samama M
J Mal Vasc; 1988; 13(3):257-61. PubMed ID: 3171405
[TBL] [Abstract][Full Text] [Related]
18. Plasma thrombomodulin levels in patients with Behçet's disease.
Düzgün N; Ayaşlioğlu E; Tutkak H; Sahin M; Aydintuğ O; Olmez U
Rheumatol Int; 2003 May; 23(3):130-3. PubMed ID: 12739044
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial function and plasma homocysteine levels in Behcet's disease.
Ozdemir R; Barutcu I; Sezgin AT; Acikgoz N; Ermis N; Esen AM; Topal E; Bariskaner E; Ozerol I
Am J Cardiol; 2004 Aug; 94(4):522-5. PubMed ID: 15325946
[TBL] [Abstract][Full Text] [Related]
20. [Blood coagulation and fibrinolysis in patients with Behçet's disease].
Fusegawa H; Ichikawa Y; Tanaka Y; Miyachi Y; Kawada T; Gondo K; Ikeda M; Shimizu H; Arimori S; Ando Y
Rinsho Byori; 1991 May; 39(5):509-16. PubMed ID: 2072574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
